TY - JOUR
T1 - INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia
AU - the INHALE WP3 Study Group and Committees
AU - Enne, Virve I.
AU - Stirling, Susan
AU - Barber, Julie A.
AU - High, Juliet
AU - Russell, Charlotte
AU - Brealey, David
AU - Dhesi, Zaneeta
AU - Colles, Antony
AU - Singh, Suveer
AU - Parker, Robert
AU - Peters, Mark
AU - Cherian, Benny P.
AU - Riley, Peter
AU - Dryden, Matthew
AU - Simpson, Ruan
AU - Patel, Nehal
AU - Cassidy, Jane
AU - Martin, Daniel
AU - Welters, Ingeborg D.
AU - Page, Valerie
AU - Kandil, Hala
AU - Tudtud, Eleanor
AU - Turner, David
AU - Horne, Robert
AU - O’Grady, Justin
AU - Swart, Ann Marie
AU - Livermore, David M.
AU - Gant, Vanya
AU - Harmston, Rebecca
AU - Wellings, Amander
AU - Vicary, Penny
AU - Thompson, Patrick
AU - McWilliams, Margaret
AU - Griffiths, Jennie
AU - Cooper, Elizabeth
AU - Livermore, David
AU - Cherian, Benny
AU - Satta, Giovanni
AU - Reynolds, Rosy
AU - Simpson, John
AU - Saunders, Katie
AU - Llewelyn, Martin
AU - Masterton, Robert
AU - Aveyard, Paul
AU - Bennett, Susan
AU - Charlett, Andre
AU - Dark, Paul
AU - Pipi, Giovanni
AU - Zhao, Xiaobei
AU - Wagner, Adam P.
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025
Y1 - 2025
N2 - Purpose: INHALE investigated the impact of seeking pathogens by PCR on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia (HAP and VAP). Methods: This pragmatic multicentre, open-label RCT enrolled adults and children with suspected HAP and VAP at 14 ICUs. Patients were randomly allocated to standard of care, or rapid in-ICU syndromic PCR coupled with optional prescribing guidance. Co-primary outcomes were superiority in antibiotic stewardship at 24 h and non-inferiority in clinical cure of pneumonia 14 days post-randomisation. Secondary outcomes included mortality, ICU length of stay and evolution of clinical scores. Results: 554 eligible patients were recruited from 5th July 2019 to 18th August 2021, with a COVID-enforced pause from 16th March 2020 and 9th July 2020. Data were analysed for 453 adults and 92 children (68.4% male; 31.6% female). ITT analysis showed 205/268 (76.5%) reviewable intervention patients receiving antibacterially appropriate and proportionate antibiotics at 24 h, versus 147/263 (55.9%) standard-of-care patients (estimated difference 21%; 95% CI 13–28%). However, only 152/268 (56.7%) intervention patients were deemed cured of pneumonia at 14 days, versus 171/265 (64.5%) standard-of-care patients (estimated difference − 6%, 95% CI − 15 to 2%; predefined non-inferiority margin -13%). Secondary mortality and ΔSOFA outcomes narrowly favoured the control arm, without clear statistical significance. Conclusions: In-ICU PCR for pathogens resulted in improved antibiotic stewardship. However, non-inferiority was not demonstrated for cure of pneumonia at 14 days. Further research should focus on clinical effectiveness studies to elucidate whether antibiotic stewardship gains achieved by rapid PCR can be safely and advantageously implemented.
AB - Purpose: INHALE investigated the impact of seeking pathogens by PCR on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia (HAP and VAP). Methods: This pragmatic multicentre, open-label RCT enrolled adults and children with suspected HAP and VAP at 14 ICUs. Patients were randomly allocated to standard of care, or rapid in-ICU syndromic PCR coupled with optional prescribing guidance. Co-primary outcomes were superiority in antibiotic stewardship at 24 h and non-inferiority in clinical cure of pneumonia 14 days post-randomisation. Secondary outcomes included mortality, ICU length of stay and evolution of clinical scores. Results: 554 eligible patients were recruited from 5th July 2019 to 18th August 2021, with a COVID-enforced pause from 16th March 2020 and 9th July 2020. Data were analysed for 453 adults and 92 children (68.4% male; 31.6% female). ITT analysis showed 205/268 (76.5%) reviewable intervention patients receiving antibacterially appropriate and proportionate antibiotics at 24 h, versus 147/263 (55.9%) standard-of-care patients (estimated difference 21%; 95% CI 13–28%). However, only 152/268 (56.7%) intervention patients were deemed cured of pneumonia at 14 days, versus 171/265 (64.5%) standard-of-care patients (estimated difference − 6%, 95% CI − 15 to 2%; predefined non-inferiority margin -13%). Secondary mortality and ΔSOFA outcomes narrowly favoured the control arm, without clear statistical significance. Conclusions: In-ICU PCR for pathogens resulted in improved antibiotic stewardship. However, non-inferiority was not demonstrated for cure of pneumonia at 14 days. Further research should focus on clinical effectiveness studies to elucidate whether antibiotic stewardship gains achieved by rapid PCR can be safely and advantageously implemented.
KW - Antibiotic stewardship
KW - Hospital-acquired pneumonia (HAP)
KW - Molecular diagnostics
KW - Point-of-care
KW - Rapid PCR
KW - Syndromic PCR
KW - Ventilator-associated pneumonia (VAP)
UR - http://www.scopus.com/inward/record.url?scp=86000470045&partnerID=8YFLogxK
U2 - 10.1007/s00134-024-07772-2
DO - 10.1007/s00134-024-07772-2
M3 - Article
C2 - 39961847
AN - SCOPUS:86000470045
SN - 0342-4642
JO - Intensive Care Medicine
JF - Intensive Care Medicine
M1 - e172352
ER -